The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link?
Abstract
Hypertension and hypertension-associated ESRD are epidemic in society. The mechanisms responsible for renal progression in mild to moderate hypertension and those groups most at risk need to be identified. Historic, epidemiologic, clinical, and experimental studies on the pathogenesis of hypertension and hypertension-associated renal disease are reviewed and an overview/hypothesis for the mechanisms involved in renal progression is presented. There is increasing evidence that hypertension may exist in one of two forms/stages. The first stage, most commonly observed in early or borderline hypertension, is characterized by salt-resistance, normal or only slightly decreased GFR, relatively normal or mild renal arteriolosclerosis, and normal renal autoregulation. This group is at minimal risk for renal progression. The second stage, characterized by salt-sensitivity, renal arteriolar disease, and blunted renal autoregulation, defines a group at highest risk for the development of microalbuminuria, albuminuria, and progressive renal disease. This second stage is more likely to be observed in blacks, in subjects with gout or hyperuricemia, with low level lead intoxication, or with severe obesity/metabolic syndrome. The two major mechanistic pathways for causing impaired autoregulation at mild to moderate elevations in BP appear to be hyperuricemia and/or low nephron number. Understanding the pathogenetic pathways mediating renal progression in hypertensive subjects should help identify those subjects at highest risk and may provide insights into new therapeutic maneuvers to slow or prevent progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Blood Pressure and End-Stage Renal Disease in Men
Klag, M. J., Whelton, P. K., Randall, B. L., Neaton, J. D., Brancati, F. L., Ford, C. E., Shulman, N. B., & Stamler, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340103 · Cited by 1,663
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Self-citationElevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Self-citationObesity-related glomerulopathy: An emerging epidemic
Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D'Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,286
Brown, M. J., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T., & Ruilope, L. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02527-7 · Cited by 1,209
Guyton, A. C., Coleman, T. G., Cowley, A. W., Scheel, K. W., Manning, R. D., & Norman, R. A. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90050-2 · Cited by 1,050
Agodoa, L. Y. (2001) · JAMA · doi:10.1001/jama.285.21.2719 · Cited by 944
The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide
Fields, L. E., Burt, V. L., Cutler, J. A., Hughes, J., Roccella, E. J., & Sorlie, P. (2004) · Hypertension · doi:10.1161/01.hyp.0000142248.54761.56 · Cited by 906
Cited by
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Uric Acid: The Oxidant-Antioxidant Paradox
Sautin, Y. Y., & Johnson, R. J. (2008) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1080/15257770802138558 · Cited by 972
Self-citationFeig, D. I., Soletsky, B., & Johnson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.924 · Cited by 914
Self-citationUric acid transport and disease
So, A., & Thorens, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42344 · Cited by 861
Metadata
- Authors
- Johnson, R. J., Segal, M. S., Srinivas, T., Ejaz, A., Mu, W., Roncal, C., Sánchez-Lozada, L. G., Gersch, M., Rodriguez-Iturbe, B., Kang, D.-H., & Acosta, J. H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-07
- Volume
- 16
- Issue
- 7
- Pages
- 1909-1919
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2117842210
- Cited by
- 280
- References
- 124
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link? https://app.cochat.ai/papers/10.1681/asn.2005010063
- The paper
- Johnson, R. J., Segal, M. S., Srinivas, T., Ejaz, A., Mu, W., Roncal, C., Sánchez-Lozada, L. G., Gersch, M., Rodriguez-Iturbe, B., Kang, D.-H., & Acosta, J. H. (2005). Essential Hypertension, Progressive Renal Disease, and Uric Acid: A Pathogenetic Link? Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2005010063
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.